Çocukluk Çağı Astımı

Global InitiativeforAsthma (GINA). Global StrategyforAsthma Management andPrevention. 2021.

Dharmage SC, Perret JL, Custovic A. Epidemiology of Asthma in ChildrenandAdults. Front Pediatr. 2019;7:246.

Koefoed HJL, Vonk JM, Koppelman GH. Predictingthecourse of asthmafromchildhooduntilearlyadulthood. CurrOpinAllergyClinImmunol. 2022;22(2):115-122.

Sawicki G, Haver K, Wood R, Redding G, TePas E. Asthma in childrenyoungerthan 12 years: Initialevaluationanddiagnosis. UpToDate. 2019.

Aydın Ö, Bavbek S, Çelik G, ve ark. Astım Tanı ve Tedavi Rehberi 2020 güncellemesi. Ankara: Buluş tasarım ve matbaacılık hizmetleri San. Tic. 2020.

Global InitiativeforAsthma (GINA). Global StrategyforAsthma Management andPrevention. 2020.

Derneği, Türk Toraks. Astım Tanı ve Tedavi Rehberi Güncellemesi. TurkThorac J. 2016;17(Suppl 1):1-96.

Daines L, McLean S, BueloA, et al. Systematicreview of clinicalpredictionmodelstosupportthediagnosis of asthma in primarycare. NPJ Prim CareRespirMed. 2019;29(1):19.

Elenius V, Chawes B, Malmberg PL, et al. Lungfunctiontestingandinflammationmarkersforwheezingpreschoolchildren: A systematicreviewforthe EAACI ClinicalPracticeRecommendations on Diagnostics of Preschool Wheeze. PediatricAllergyandImmunology. 2021;32(3):501-513.

Brand PL, Duiverman EJ, Waalkens HJ, van Essen-Zandvliet EE, Kerrebijn KF. Peakflowvariation in childhoodasthma: correlationwithsymptoms, airwaysobstruction, andhyperresponsivenessduringlong-termtreatmentwithinhaledcorticosteroids. Dutch CNSLD StudyGroup. Thorax. 1999;54(2):103-107.

Expert Panel Report 3 (EPR-3): GuidelinesfortheDiagnosisand Management of Asthma-Summary Report 2007. J AllergyClinImmunol. 2007;120(5 Suppl):94-138.

Evans SE, Scanlon PD, editors. Currentpractice in pulmonaryfunctiontesting. Mayo ClinProc; 2003;78(6):758-763

Society BT. ScottishIntercollegiateGuidelines Network (SIGN). British Guideline on the Management of Asthma. Thorax. 2008;63 (Suppl 4): 1-121.

Demoly P, Pipet A, Bousquet J. Skin Testing in Diagnosisand Management of RespiratoryAllergicDiseases. AllergyandAllergicDiseases. 2008;1:1335-1345.

Crapo RO, Casaburi R, Coates AL, et al. Guidelinesformethacholineandexercisechallenge testing-1999. Thisofficialstatement of theAmericanThoracicSocietywasadoptedbythe ATS Board of Directors, July 1999. Am J RespirCritCareMed. 2000;161(1):309-329.

Arakawa H, Adachi Y, Ebisawa M, Fujisawa T. Japaneseguidelinesforchildhoodasthma 2020. AllergolInt. 2020;69(3):314-330.

Szefler SJ, Baker JW, Uryniak T, Goldman M, Silkoff PE. Comparativestudy of budesonideinhalationsuspensionandmontelukast in youngchildrenwithmildpersistentasthma. J AllergyClinImmunol. 2007;120(5):1043-1050.

Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-terminhaledcorticosteroids in preschoolchildren at high risk forasthma. N Engl J Med. 2006;354(19):1985-1997.

Adams NP, Bestall JB, Malouf R, Lasserson TJ, Jones PW. Inhaledbeclomethasoneversusplaceboforchronicasthma. Cochrane Database SystRev. 2005;2005(1):Cd002738.

Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotrienereceptorantagonist, forthetreatment of persistentasthma in childrenaged 2 to 5 years. Pediatrics. 2001;108(3):48.

FDA requiresBoxedWarningaboutseriousmentalhealthsideeffectsforasthmaandallergydrugmontelukast (Singulair); advisesrestrictinguseforallergic rhinitis.2020.

Patel B, Khine H, Shah A, et al. Randomizedclinicaltrial of highconcentrationversustitratedoxygenuse in pediatricasthma. Pediatr Pulmonol. 2019;54(7):970-976.

Naureckas ET, Dukic V, Bao X, Rathouz P. Short-acting beta-agonistprescriptionfills as a marker forasthmamorbidity. Chest. 2005;128(2):602-608.

Carl JC, Myers TR, Kirchner HL, Kercsmar CM. Comparison of racemicalbuterolandlevalbuterolfortreatment of acuteasthma. J Pediatr. 2003;143(6):731-736.

Chang AB, Clark R, Sloots TP, et al. A 5- versus 3-day course of oral corticosteroidsforchildrenwithasthmaexacerbationswhoare not hospitalised: a randomisedcontrolledtrial. Med J Aust. 2008;189(6):306-310.

Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in thetreatment of childrenandadultswithacuteasthma: a systematicreviewwith meta-analysis. Thorax. 2005;60(9):740-746.

Griffiths B, Ducharme FM. Combinedinhaledanticholinergicsandshort‐acting beta 2‐agonists forinitialtreatment of acuteasthma in children. Cochrane Database SystRev2013(8).

Griffiths B, Kew KM. Intravenousmagnesiumsulfatefortreatingchildrenwithacuteasthma in theemergencydepartment. Cochrane Database SystRev. 2016;4(4):Cd011050.

Scarfone RJ, Loiselle JM, Joffe MD, et al. A randomizedtrial of magnesium in theemergencydepartmenttreatment of childrenwithasthma. Annals of emergencymedicine. 2000;36(6):572-578.

Global InitiativeforAsthma (GINA). Global StrategyforAsthma Management andPrevention. 2021.

Dharmage SC, Perret JL, Custovic A. Epidemiology of Asthma in ChildrenandAdults. Front Pediatr. 2019;7:246.

Koefoed HJL, Vonk JM, Koppelman GH. Predictingthecourse of asthmafromchildhooduntilearlyadulthood. CurrOpinAllergyClinImmunol. 2022;22(2):115-122.

Sawicki G, Haver K, Wood R, Redding G, TePas E. Asthma in childrenyoungerthan 12 years: Initialevaluationanddiagnosis. UpToDate. 2019.

Aydın Ö, Bavbek S, Çelik G, ve ark. Astım Tanı ve Tedavi Rehberi 2020 güncellemesi. Ankara: Buluş tasarım ve matbaacılık hizmetleri San. Tic. 2020.

Global InitiativeforAsthma (GINA). Global StrategyforAsthma Management andPrevention. 2020.

Derneği, Türk Toraks. Astım Tanı ve Tedavi Rehberi Güncellemesi. TurkThorac J. 2016;17(Suppl 1):1-96.

Daines L, McLean S, BueloA, et al. Systematicreview of clinicalpredictionmodelstosupportthediagnosis of asthma in primarycare. NPJ Prim CareRespirMed. 2019;29(1):19.

Elenius V, Chawes B, Malmberg PL, et al. Lungfunctiontestingandinflammationmarkersforwheezingpreschoolchildren: A systematicreviewforthe EAACI ClinicalPracticeRecommendations on Diagnostics of Preschool Wheeze. PediatricAllergyandImmunology. 2021;32(3):501-513.

Brand PL, Duiverman EJ, Waalkens HJ, van Essen-Zandvliet EE, Kerrebijn KF. Peakflowvariation in childhoodasthma: correlationwithsymptoms, airwaysobstruction, andhyperresponsivenessduringlong-termtreatmentwithinhaledcorticosteroids. Dutch CNSLD StudyGroup. Thorax. 1999;54(2):103-107.

Expert Panel Report 3 (EPR-3): GuidelinesfortheDiagnosisand Management of Asthma-Summary Report 2007. J AllergyClinImmunol. 2007;120(5 Suppl):94-138.

Evans SE, Scanlon PD, editors. Currentpractice in pulmonaryfunctiontesting. Mayo ClinProc; 2003;78(6):758-763

Society BT. ScottishIntercollegiateGuidelines Network (SIGN). British Guideline on the Management of Asthma. Thorax. 2008;63 (Suppl 4): 1-121.

Demoly P, Pipet A, Bousquet J. Skin Testing in Diagnosisand Management of RespiratoryAllergicDiseases. AllergyandAllergicDiseases. 2008;1:1335-1345.

Crapo RO, Casaburi R, Coates AL, et al. Guidelinesformethacholineandexercisechallenge testing-1999. Thisofficialstatement of theAmericanThoracicSocietywasadoptedbythe ATS Board of Directors, July 1999. Am J RespirCritCareMed. 2000;161(1):309-329.

Arakawa H, Adachi Y, Ebisawa M, Fujisawa T. Japaneseguidelinesforchildhoodasthma 2020. AllergolInt. 2020;69(3):314-330.

Szefler SJ, Baker JW, Uryniak T, Goldman M, Silkoff PE. Comparativestudy of budesonideinhalationsuspensionandmontelukast in youngchildrenwithmildpersistentasthma. J AllergyClinImmunol. 2007;120(5):1043-1050.

Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-terminhaledcorticosteroids in preschoolchildren at high risk forasthma. N Engl J Med. 2006;354(19):1985-1997.

Adams NP, Bestall JB, Malouf R, Lasserson TJ, Jones PW. Inhaledbeclomethasoneversusplaceboforchronicasthma. Cochrane Database SystRev. 2005;2005(1):Cd002738.

Knorr B, Franchi LM, Bisgaard H, et al. Montelukast, a leukotrienereceptorantagonist, forthetreatment of persistentasthma in childrenaged 2 to 5 years. Pediatrics. 2001;108(3):48.

FDA requiresBoxedWarningaboutseriousmentalhealthsideeffectsforasthmaandallergydrugmontelukast (Singulair); advisesrestrictinguseforallergic rhinitis.2020.

Patel B, Khine H, Shah A, et al. Randomizedclinicaltrial of highconcentrationversustitratedoxygenuse in pediatricasthma. Pediatr Pulmonol. 2019;54(7):970-976.

Naureckas ET, Dukic V, Bao X, Rathouz P. Short-acting beta-agonistprescriptionfills as a marker forasthmamorbidity. Chest. 2005;128(2):602-608.

Carl JC, Myers TR, Kirchner HL, Kercsmar CM. Comparison of racemicalbuterolandlevalbuterolfortreatment of acuteasthma. J Pediatr. 2003;143(6):731-736.

Chang AB, Clark R, Sloots TP, et al. A 5- versus 3-day course of oral corticosteroidsforchildrenwithasthmaexacerbationswhoare not hospitalised: a randomisedcontrolledtrial. Med J Aust. 2008;189(6):306-310.

Rodrigo GJ, Castro-Rodriguez JA. Anticholinergics in thetreatment of childrenandadultswithacuteasthma: a systematicreviewwith meta-analysis. Thorax. 2005;60(9):740-746.

Griffiths B, Ducharme FM. Combinedinhaledanticholinergicsandshort‐acting beta 2‐agonists forinitialtreatment of acuteasthma in children. Cochrane Database SystRev2013(8).

Griffiths B, Kew KM. Intravenousmagnesiumsulfatefortreatingchildrenwithacuteasthma in theemergencydepartment. Cochrane Database SystRev. 2016;4(4):Cd011050.

Scarfone RJ, Loiselle JM, Joffe MD, et al. A randomizedtrial of magnesium in theemergencydepartmenttreatment of childrenwithasthma. Annals of emergencymedicine. 2000;36(6):572-578.